ALS PCS — PCP & PCP-IV DIRECTIVES (2025)
Source: ALS PCS v5.4 (April 2025)
Scope: Primary Care Paramedic + PCP-IV Certified

────────────────────────────────────────
1. Bronchoconstriction (PCP)
────────────────────────────────────────
Indications:
- Respiratory distress with suspected bronchoconstriction (e.g., asthma, COPD)

Treatment:
- Salbutamol MDI 800 mcg (8 puffs) q5–15 min PRN
  OR
- Salbutamol Neb 5 mg if no MDI available
- Epinephrine IM 0.01 mg/kg (max 0.5 mg) if severe + asthma

Contraindications:
- Allergy to salbutamol or epinephrine

────────────────────────────────────────
2. Hypoglycemia (PCP + PCP-IV)
────────────────────────────────────────
Indications:
- Altered LOC with BGL < 4.0 mmol/L

Treatment:
- Oral glucose 25–50 g if alert and able to swallow
- D10W IV (PCP-IV): 0.2 g/kg (2 mL/kg) up to 10 g (100 mL)
- Glucagon IM 1 mg if no IV access

Contraindications:
- Allergy
- Glucagon contraindicated in pheochromocytoma

────────────────────────────────────────
3. Cardiac Ischemia (PCP + PCP-IV)
────────────────────────────────────────
Indications:
- Suspected cardiac chest pain

Treatment:
- ASA 160–162 mg PO once
- Nitroglycerin SL (PCP-IV): 0.3–0.6 mg q5 min, max 6 doses

Conditions:
- HR 60–159 bpm
- SBP ≥ 100 mmHg
- No ED medications in past 48 hrs

Contraindications:
- Hypotension, bradycardia, tachycardia, ED drug use

────────────────────────────────────────
4. Medical Cardiac Arrest (PCP)
────────────────────────────────────────
Indications:
- Non-traumatic cardiac arrest

Treatment:
- High-quality CPR + Defibrillation (AED or Manual)
- Apply Medical TOR if:
  • Arrest not witnessed by EMS
  • No ROSC
  • No shocks delivered

Transport if:
- No ROSC after 3 analyses

────────────────────────────────────────
5. ROSC – Return of Spontaneous Circulation (PCP)
────────────────────────────────────────
Treatment:
- Oxygen to SpO₂ 94–98%
- Avoid hyperventilation
- Monitor vitals closely
- Prepare for re-arrest
- 12-lead ECG if available

────────────────────────────────────────
6. CPAP (PCP-Certified)
────────────────────────────────────────
Indications:
- Severe SOB (COPD, CHF, pulmonary edema)

Treatment:
- Start at 5 cmH₂O, titrate to max 10 cmH₂O

Contraindications:
- GCS < Alert
- Vomiting
- Facial trauma
- Hypotension

────────────────────────────────────────
7. Allergic Reaction / Anaphylaxis (PCP + PCP-IV)
────────────────────────────────────────
Treatment:
- Epinephrine IM 0.01 mg/kg (max 0.5 mg) q5–15 min ×2
- Diphenhydramine (PCP-IV): 25–50 mg IM or IV

Contraindications:
- None for epinephrine in anaphylaxis

────────────────────────────────────────
8. Nausea / Vomiting (PCP-IV)
────────────────────────────────────────
Treatment:
- Dimenhydrinate 25–50 mg IV or IM q4h PRN

Contraindications:
- Allergy
- Glaucoma

────────────────────────────────────────
9. Pain Management (PCP-IV)
────────────────────────────────────────
Indications:
- Moderate to severe pain

Treatment:
- Acetaminophen 960–1000 mg PO
- Ibuprofen 400 mg PO
- Ketorolac 10–15 mg IM/IV if NPO or cannot tolerate oral

Contraindications:
- NSAID allergy, renal failure, bleeding, pregnancy
- Do not combine ibuprofen and ketorolac

────────────────────────────────────────
10. Seizures (PCP)
────────────────────────────────────────
Treatment:
- Ensure scene safety
- Airway and oxygen support
- BGL check
- Monitor postictal phase
- Midazolam only with delegation or patch

────────────────────────────────────────
11. Stroke / TIA (PCP)
────────────────────────────────────────
Indications:
- Acute neurologic deficits < 4.5 hours since onset

Treatment:
- FAST / BE-FAST screening
- Apply Stroke Bypass Protocol
- Confirm BGL > 3.0 mmol/L
- Expedite transport, minimize scene time

────────────────────────────────────────
12. TOR & DNR (PCP)
────────────────────────────────────────
Treatment:
- Apply Medical TOR as per directive
- Confirm and honor valid DNR forms
- Document clearly

────────────────────────────────────────
13. TXA – Tranexamic Acid (PCP-IV)
────────────────────────────────────────
Indications:
- Blunt or penetrating trauma with signs of hemorrhagic shock (e.g., SBP < 90 mmHg, HR > 110 bpm)
- Suspected significant internal or external bleeding
- Injury occurred within the past 3 hours

Treatment:
- TXA 1 g IV/IO over 10 minutes (infusion or slow push)
- May dilute in 100 mL NS/D5W or administer via pump

Contraindications:
- Known allergy to TXA
- Traumatic arrest
- Isolated head injury
- More than 3 hours since injury

Notes:
- Must be used in conjunction with hemorrhage control and rapid transport
